Measuring the quality of sentinel lymph node biopsy in breast cancer using newly developed quality indicators: A feasibility study

Annals of Surgical Oncology

Volumn 18, Issue 1, 2011, Pages 78-85

  Wells, Bryan J ^a,c   Najjar, Hesham ^a,c   Wright, Frances C ^a,c   Holloway, Claire M B ^a,c   Fraser, Novlette ^a,c   McCready, David ^a,c   Quan, May Lynn ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CANCER; BREAST SURGERY; CANCER PATIENT; CANCER STAGING; CHINESE MEDICINE; CLINICAL PROTOCOL; DELPHI STUDY; FEASIBILITY STUDY; FEMALE; HEALTH CENTER; HOSPITAL; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; QUALITATIVE ANALYSIS; QUALITY CONTROL; REGISTER; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; TREATMENT REFUSAL;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY INDICATORS, HEALTH CARE; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 78651375085     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1190-1     Document Type: Article

References (35)

1. DN Krag DL Weaver JC Alex JT Fairbank 1993 Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe Surg Oncol 2 6 335 339 1:STN:280:DyaK2c7nslegtQ%3D%3D 10.1016/0960- 7404(93)90064-6 8130940
2. Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional lymph nodes. Analysis of prognostic factors in 1134 patients from John Wayne Cancer Clinic. Ann Surg. 1991;214(4):491-9.
3. AE Giuliano DM Kirgan JM Guenther DL Morton 1994 Lymphatic mapping and sentinel lymphadenectomy for breast cancer Ann Surg 220 391 401 1:STN:280:DyaK2cznvFyksA%3D%3D 10.1097/00000658-199409000-00015 8092905
4. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999;91:368-73.
5. SL Wong C Chao MJ Edwards, et al. 2001 Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers Am Surg 67 6 522 526 1:STN:280:DC%2BD3MzkslSntg%3D%3D 11409798
6. DM Miltenburg C Miller TB Karamlou FC Brunicardi 1999 Meta-analysis of sentinel lymph node biopsy in breast cancer J Surg Res 84 138 142 1:STN:280:DyaK1M3ovVWlsw%3D%3D 10.1006/jsre.1999.5629 10357910
7. KM McMasters TM Tuttle DJ Carlson, et al. 2000 Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used J Clin Oncol 18 13 2560 2566 1:STN:280:DC%2BD3czlt1Snuw%3D%3D 10893287
8. RC Martin MJ Edward SL Wong, et al. 2000 Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study Surgery 128 139 144 10.1067/msy.2000.108064 10922983
9. DN Krag D Weaver T Ashikaga, et al. 1998 The sentinel node in breast cancer-a multicenter validation study N Engl J Med 339 14 941 946 1:STN:280:DyaK1cvhvVKntg%3D%3D 10.1056/NEJM199810013391401 9753708
10. L Bergkvist J Frisell G Liljegren F Celebroglu S Damm M Thorn 2001 Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer Br J Surg 88 1644 1648 1:STN:280:DC%2BD3Mnptlantg%3D%3D 10.1046/j.0007-1323.2001.01948.x 11736980
11. HS Cody J Fey T Akhurst, et al. 2001 Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures Ann Surg Oncol 8 13 19 10.1007/s10434-001-0013-9 11206218
12. L Tafra DR Lannin MS Swanson, et al. 2001 Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye Ann Surg 233 1 51 59 1:STN:280:DC%2BD3M3pvFCrsg%3D%3D 10.1097/00000658-200101000-00009 11141225
13. DN Krag SJ Anderson TB Julian, et al. 2007 Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial Lancet Oncol 8 10 881 888 1:CAS:528: DC%2BD2sXhtFektbzM 10.1016/S1470-2045(07)70278-4 17851130
14. RE Mansel L Fallowfield M Kissin, et al. 2006 Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial J Natl Cancer Inst 98 9 599 609 10.1093/jnci/djj158 16670385
15. G Zavagno GL De Salvo G Scalco, et al. 2008 A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial Ann Surg 247 2 207 213 10.1097/SLA.0b013e31812e6a73 18216523
16. U Veronesi G Paganelli G Viale, et al. 2006 Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study Lancet Oncol 7 12 983 990 10.1016/S1470-2045(06)70947-0 17138219
17. U Veronesi G Paganelli G Viale, et al. 2003 A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 6 546 553 10.1056/NEJMoa012782 12904519
18. GH Lyman AE Giuliano MR Somerfield, et al. 2005 American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 30 7703 7720 10.1200/JCO.2005.08.001 16157938
19. George R, Quan ML, McCready DR, McLeod R, Rumble RB and the Expert Panel on SLNB in Breast Cancer. Sentinel lymph node biopsy in early-stage breast cancer: guideline recommendations. Cancer Care Ontario (CCO). Evidence-based series #17-5: Section 1. http://www.cancercare.on.ca/common/pages/UserFile.aspx? fileId=45872. Accessed 3 April 2010.
20. ML Quan BJ Wells FC Wright N Fraser D McCready AR Gagilardi 2010 Beyond the false negative rate: development of quality indicators for sentinel lymph node biopsy in breast cancer Ann Surg Oncol. 17 2 579 591 10.1245/s10434-009- 0658-3 19707833
21. A Rivers N Hansen 2007 Axillary management after sentinel lymph node biopsy in breast cancer patients Surg Clin North Am 87 2 365 377 10.1016/j.suc.2007.01.014 17498532
22. S Samphao JM Eremin M El-Sheemy O Eremin 2008 Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach Ann Surg Oncol 15 5 1282 1296 10.1245/s10434-008-9863-8 18330650
23. GF Schwartz AE Giuliano U Veronesi 2002 Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia, Pennsylvania Hum Pathol 33 6 579 589 10.1053/hupa.2002.124117 12152156
24. D McCready C Holloway W Shelley, et al. 2005 Surgical management of early stage invasive breast cancer: a practice guideline Can J Surg 48 3 185 194 16013621
25. EJ Rutgers 2005 Guidelines to assure quality in breast cancer surgery Eur J Surg Oncol 31 6 568 576 10.1016/j.ejso.2005.02.008 16023942
26. Lucci A, Kelemen PR, Miller III C, Chardkoff L, Wilson L. National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg. 2001;192(4):453-8.
27. ML Quan N Hodgson P Lovrics G Porter B Poirier FC Wright 2008 National adoption of sentinel node biopsy for breast cancer: lessons learned from the Canadian experience Breast J 14 5 421 427 10.1111/j.1524-4741.2008.00617.x 18657140
28. ML Quan D McCready 2009 The evolution of lymph node assessment in breast cancer J Surg Oncol. 99 4 194 8 10.1002/jso.21201 19021226
29. Greene FL, Page DL, Fleming ID. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.
30. Helyer LK, Coburn NG, Law CH, McCready DR. Does the adoption of sentinel node biopsy account for the increase in node positivity in women with T1 tumors? Ann Surg Oncol. 2008;15(S2):75.
31. Helyer LK, Coburn NG, Law CH, McCready DR. Axillary staging is more accurate today than ever before: no increase in the false negative rate with wide-spread adoption of sentinel node technique. Breast Can Surg Treat. 2007;106(S1):s127-8.
32. Najjar H, SLNB quality indicator measurement at Princess Margaret Hospital. Personal communication, 2008.
33. HM Schachter V Mamaladze G Lewin ID Graham M Brouwers M Sampson, et al. 2006 Many quality measurements, but few quality measures assessing the quality of breast cancer care in women: a systematic review BMC Cancer 6 291 10.1186/1471-2407-6-291 17176480
34. R Ramjeesingh ML Quan S Gardner CMB Holloway 2009 Prediction of involvement of sentinel and nonsentinel lymph nodes in a Canadian population with breast cancer Can J Surg 52 1
35. CE Desch KK McNiff EC Schneider D Schrag J McClure E Lepisto, et al. 2008 American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures J Clin Oncol 26 21 3631 3637 10.1200/JCO.2008.16.5068 18640941